Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and pyrimidinones

cyc 202 has been researched along with pyrimidinones in 3 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(pyrimidinones)		Trials
(pyrimidinones)		Recent Studies (post-2010) (pyrimidinones)
97973936,0596042,692

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colanesi, S; Ishizaki, H; Kelsh, RN; Liu, D; Lundegaard, PR; North, TE; Patton, EE; Taylor, KL; Temperley, ND1
Borgmann, K; Dahm-Daphi, J; Dikomey, E; Mansour, WY; Petersen, C1
Lawrence, TS; Maybaum, J; Morgan, MA; Parsels, JD; Parsels, LA; Tanska, DM1

Other Studies

3 other study(ies) available for cyc 202 and pyrimidinones

ArticleYear
Small molecule screening identifies targetable zebrafish pigmentation pathways.
    Pigment cell & melanoma research, 2012, Volume: 25, Issue:2

    Topics: Animals; Cell Count; Chromatophores; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Embryo, Nonmammalian; Heterocyclic Compounds, 3-Ring; Melanocytes; Metabolic Networks and Pathways; Phenotype; Pigmentation; Purines; Pyrimidinones; Roscovitine; Small Molecule Libraries; Tyrphostins; Zebrafish

2012
The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining.
    DNA repair, 2013, Volume: 12, Issue:12

    Topics: Animals; Antigens, Nuclear; CHO Cells; Chromatin; Cricetulus; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA-Binding Proteins; Gene Expression Regulation; Humans; Ku Autoantigen; Mutation; Nuclear Proteins; Poly(ADP-ribose) Polymerases; Purines; Pyrimidinones; Roscovitine; Thiones

2013
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.
    Cell cycle (Georgetown, Tex.), 2018, Volume: 17, Issue:9

    Topics: Analysis of Variance; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Deoxycytidine; DNA Replication; Gemcitabine; Histones; Humans; Nucleosides; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Roscovitine; Staining and Labeling

2018